Drug details

Striverdi Respimat (olodaterol inhalation spray)

type of Beta2 Agonists

Striverdi Respimat (olodaterol) Inhalation Spray is a selective beta2-adrenergic bronchodilator used for long-term, once-daily maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.

The drug is often used to treat Chronic obstructive pulmonary disease .

This drug may have the following side effects:

• rash,
• diarrhea,
• dizziness,
• upper respiratory tract infection,
• joint pain,
• back pain,
• cough,
• sore throat,
• pneumonia,
• runny or stuffy nose,
• urinary tract infection,
• fever.
• constipation, and
• bronchitis,

The following drugs are related to Striverdi Respimat, either as a replacement or used together:

• Tudorza Pressair (aclidinium bromide)
• Adempas (riociguat tablets)
• Breo Ellipta (fluticasone furoate and vilanterol inhalation powder)
• Breztri Aerosphere (budesonide, glycopyrrolate, and formoterol fumarate inhalation aerosol)
• Symbicort Aerosphere (budesonide and formoterol fumarate inhalation aerosol)
• Combivent Respimat (ipratropium bromide and albuterol)
• Incruse Ellipta (umeclidinium inhalation powder)
• Utibron Neohaler (indacaterol and glycopyrrolate inhalation powder, for oral inhalation use)
• Yupelri (revefenacin inhalation solution)
• Serevent Diskus (salmeterol xinafoate)
• Spiriva (tiotropium bromide)
• Stiolto Respimat (tiotropium bromide and olodaterol)